While obstacles may persist with limited access for patients and researchers, technology can help with this cancer clinical trial paradox.
David M. Kronfeld
Advertisement
Articles by David M. Kronfeld
David M. Kronfeld, the Head of Real World Data Innovation for Medidata, writes of Mercy Hospital in Joplin, Missouri, that despite seeing over 600 new cancer patients each year, it has historically had very limited access to clinical trials
Advertisement
Latest Updated Articles
- The Cancer Trial Paradox – Too Few Patients to Some, Too Few Trials to Others
Published: June 6th 2019 | Updated:
The Cancer Trial Paradox: Too Few Patients to Some, Too Few Trials to OthersPublished: July 1st 2019 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
2
2025 SCRS Global Site Solutions Summit: How Technology Vendors Can Reduce Site Burden and Improve Trial Execution
3
AI in Action: Breaking Down Clinical Trial Bottlenecks
4
Unlocking the Potential of Agentic AI to Reduce Trial Delays
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
